3334 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 67 | next »
Genei
Gene descriptioni x
Protein classi x
Tissue
Cell
Pathology
Subcellular locationi x
Prognostic p-valuei x
RNA cancer categoryi x
RNA tissue categoryi x
A1CFAPOBEC1 complementation factorPredicted intracellular proteins
NucleoplasmTissue enrichedTissue enhanced
A2ML1Alpha-2-macroglobulin like 1Predicted intracellular proteins
Predicted secreted proteins
Tissue enhancedTissue enriched
AADACArylacetamide deacetylaseEnzymes
Predicted intracellular proteins
Ovarian cancer: 5.58e-6
Stomach cancer: 2.19e-4
Pancreatic cancer: 5.02e-4
Tissue enrichedGroup enriched
AATKApoptosis associated tyrosine kinaseEnzymes
Predicted intracellular proteins
Predicted membrane proteins
MitochondriaMixedTissue enhanced
ABCA12ATP binding cassette subfamily A member 12Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoli
Vesicles
Plasma membrane
Cytosol
MixedGroup enriched
ABCA8ATP binding cassette subfamily A member 8Predicted membrane proteins
Transporters
Nucleoplasm
Cytosol
MixedMixed
ABCB1ATP binding cassette subfamily B member 1Cancer-related genes
CD markers
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Focal adhesion sites
Cytosol
Renal cancer: 2.95e-4
Pancreatic cancer: 3.33e-4
Tissue enhancedTissue enhanced
ABCB9ATP binding cassette subfamily B member 9Predicted intracellular proteins
Predicted membrane proteins
Transporters
VesiclesGlioma: 4.62e-4
MixedTissue enhanced
ABCC2ATP binding cassette subfamily C member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Renal cancer: 1.93e-5
Tissue enhancedGroup enriched
ABCC3ATP binding cassette subfamily C member 3Cancer-related genes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 4.68e-6
Pancreatic cancer: 9.57e-4
MixedMixed
ABCC4ATP binding cassette subfamily C member 4Plasma proteins
Predicted membrane proteins
Transporters
Renal cancer: 2.25e-10
Endometrial cancer: 9.89e-4
Tissue enrichedTissue enhanced
ABCC6ATP binding cassette subfamily C member 6Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Plasma membraneLiver cancer: 3.82e-4
Tissue enhancedTissue enhanced
ABCC9ATP binding cassette subfamily C member 9Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Cytosol
Renal cancer: 1.85e-5
MixedMixed
ABCG2ATP binding cassette subfamily G member 2 (Junior blood group)Cancer-related genes
CD markers
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Plasma membrane
MixedTissue enhanced
ABCG5ATP binding cassette subfamily G member 5Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
NucleusLiver cancer: 2.60e-5
Tissue enrichedGroup enriched
ABCG8ATP binding cassette subfamily G member 8Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
VesiclesTissue enrichedGroup enriched
ABI3BPABI family member 3 binding proteinPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 6.14e-4
MixedMixed
ABLIM2Actin binding LIM protein family member 2Predicted intracellular proteins
Nucleoplasm
Mitochondria
MixedTissue enhanced
ABLIM3Actin binding LIM protein family member 3Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Cell Junctions
Renal cancer: 1.28e-4
MixedTissue enhanced
ABOABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferasePredicted membrane proteins
MixedTissue enhanced
AC009014.3Predicted membrane proteins
Liver cancer: 1.63e-4
Pancreatic cancer: 6.13e-4
Tissue enhancedTissue enhanced
AC113404.1Ras-related protein Rap-1b-like protein Predicted intracellular proteins
MixedTissue enriched
ACANAggrecanPredicted intracellular proteins
Predicted secreted proteins
Renal cancer: 1.47e-6
MixedTissue enhanced
ACBD7Acyl-CoA binding domain containing 7Predicted intracellular proteins
Vesicles
Cytosol
MixedTissue enriched
ACE2Angiotensin I converting enzyme 2Enzymes
FDA approved drug targets
Predicted membrane proteins
Renal cancer: 2.12e-5
Liver cancer: 4.21e-4
Tissue enhancedGroup enriched
ACER2Alkaline ceramidase 2Enzymes
Predicted membrane proteins
Tissue enhancedGroup enriched
ACHEAcetylcholinesterase (Cartwright blood group)Blood group antigen proteins
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Renal cancer: 3.88e-5
Glioma: 7.16e-4
MixedTissue enhanced
ACKR4Atypical chemokine receptor 4G-protein coupled receptors
Predicted membrane proteins
Vesicles
Mitochondria
MixedMixed
ACOT11Acyl-CoA thioesterase 11Predicted intracellular proteins
CytosolRenal cancer: 3.07e-8
Colorectal cancer: 9.37e-4
MixedMixed
ACOX2Acyl-CoA oxidase 2Enzymes
Predicted intracellular proteins
Vesicles
Cytosol
Tissue enhancedTissue enhanced
ACPPAcid phosphatase, prostateCancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enrichedTissue enriched
ACRBPAcrosin binding proteinPredicted secreted proteins
Nucleoplasm
Vesicles
MixedTissue enriched
ACSM3Acyl-CoA synthetase medium-chain family member 3Enzymes
Predicted intracellular proteins
Renal cancer: 9.88e-6
Ovarian cancer: 1.97e-4
MixedTissue enhanced
ACTA1Actin, alpha 1, skeletal muscleDisease related genes
Plasma proteins
Predicted intracellular proteins
Group enrichedTissue enriched
ACTC1Actin, alpha, cardiac muscle 1Disease related genes
Plasma proteins
Predicted intracellular proteins
Head and neck cancer: 3.72e-5
Urothelial cancer: 9.32e-4
Group enrichedTissue enriched
ACTL10Actin like 10Predicted secreted proteins
MixedTissue enriched
ACTL8Actin like 8Predicted intracellular proteins
CytosolEndometrial cancer: 1.62e-6
Head and neck cancer: 7.02e-4
MixedTissue enriched
ACTN2Actinin alpha 2Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Transporters
Tissue enhancedGroup enriched
ACTR3CARP3 actin-related protein 3 homolog CPredicted intracellular proteins
MixedTissue enriched
ACTRT3Actin related protein T3Predicted intracellular proteins
NucleoplasmEndometrial cancer: 4.11e-4
MixedTissue enriched
ACVR1CActivin A receptor type 1CEnzymes
Predicted membrane proteins
Predicted secreted proteins
MixedTissue enriched
ACY3Aminoacylase 3Enzymes
Predicted intracellular proteins
Endometrial cancer: 4.80e-4
MixedTissue enhanced
ADAM12ADAM metallopeptidase domain 12Predicted membrane proteins
Predicted secreted proteins
Transporters
Plasma membraneRenal cancer: 2.39e-14
MixedTissue enriched
ADAM22ADAM metallopeptidase domain 22Predicted membrane proteins
Predicted secreted proteins
Cell JunctionsMixedTissue enhanced
ADAM23ADAM metallopeptidase domain 23Predicted intracellular proteins
Predicted membrane proteins
MixedGroup enriched
ADAM28ADAM metallopeptidase domain 28Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Plasma membrane
Mitochondria
Endometrial cancer: 3.17e-4
MixedTissue enhanced
ADAM33ADAM metallopeptidase domain 33Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Nuclear speckles
Plasma membrane
MixedMixed
ADAMTS12ADAM metallopeptidase with thrombospondin type 1 motif 12Plasma proteins
Predicted secreted proteins
Nucleoli
Mitochondria
Urothelial cancer: 6.78e-4
MixedMixed
ADAMTS13ADAM metallopeptidase with thrombospondin type 1 motif 13Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
MixedMixed
ADAMTS14ADAM metallopeptidase with thrombospondin type 1 motif 14Cancer-related genes
Plasma proteins
Predicted secreted proteins
CytosolMixedTissue enhanced
Page of 67 | next »